CAC
OPNT

Certified Advisory Corp’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Certified Advisory Corp’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$5K – 784
2021
Q1 		$5K Buy
+500
New +$5.7K ﹤0.01% 682

Other funds holding OPNT

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Certified Advisory Corp's OPNT Position: Q2 2021 in Review

Certified Advisory Corp sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q2 2021, closing a stake of 500 shares — an estimated $5K sold.

Certified Advisory Corp first reported a position in OPNT in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 26 funds tracked by Wall St. Rank hold OPNT as of Q2 2021.

  • Certified Advisory Corp reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Certified Advisory Corp sold 500 Opiant Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $5K.
  • Certified Advisory Corp first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Certified Advisory Corp's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $5K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.